文献速递核素与放射性配体治疗肿瘤 PET/CT

双同位素采集166Ho标记微球与99mTc-甲溴芬宁用于放射性栓塞治疗计划

Radioembolization Planning With Dual-Isotope Acquisition of 166 Ho-Labeled Microparticles and 99m Tc-Mebrofenin.
PubMed 文献 · Clin Nucl Med · 2023-06-08

一例76岁肝细胞癌患者,因既往左半肝切除,在右肝动脉超选择性注射166Ho微球前进行SPECT/CT显像时,同步静脉注射99mTc-甲溴芬宁行功能性体积SPECT。基于两套图像计算未受照健康肝体积为1589 mL(99mTc-甲溴芬宁SPECT功能肝储备85.5%)。治疗后剂量计算显示正常组织和肿瘤吸收剂量均理想,患者3个月后临床状况良好。

要点

  • 在166Ho微球SPECT/CT显像时同步行99mTc-甲溴芬宁功能性体积SPECT,可评估未受照健康肝。
  • 该例未受照健康肝体积计算为1589 mL,功能肝储备为85.5%。
  • 治疗后剂量计算显示正常组织与肿瘤吸收剂量均理想,患者3个月后临床状况良好。

核心结论

  • 双同位素166Ho微球与99mTc-甲溴芬宁SPECT/CT采集用于肝放射性栓塞治疗计划,该例治疗后剂量计算显示正常组织和肿瘤吸收剂量均理想,患者3个月后临床状况良好。

研究设计与样本

  • 一例76岁肝细胞癌患者,既往行左半肝切除,转诊行肝放射性栓塞治疗。

主要发现

  • 在右肝动脉超选择性注射166Ho微球前,于SPECT/CT显像时同步静脉注射99mTc-甲溴芬宁行功能性体积SPECT。
  • 基于两套图像计算未受照健康肝体积为1589 mL,99mTc-甲溴芬宁SPECT显示功能肝储备为85.5%。
  • 治疗后剂量计算显示正常组织和肿瘤吸收剂量均理想,患者3个月后临床状况良好。

关键数值与推荐

  • 未受照健康肝体积为1589 mL,功能肝储备为85.5%(基于99mTc-甲溴芬宁SPECT)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 76-year-old man with hepatocellular carcinoma was referred for liver radioembolization. Given a prior left hemihepatectomy, it was clinically important to consider potentially irradiated healthy liver at planning. Thus, at the SPECT/CT imaging of the scout dose 166 Ho-microparticles before injected superselectively in the right hepatic artery, 99m Tc-mebrofenin was injected intravenously, and functional volumetry SPECT was performed simultaneously. Based on the 2 image sets, the nonirradiated healthy liver was calculated as 1589 mL (functional liver reserve of 85.5% on 99m Tc-mebrofenin SPECT). Posttreatment dosimetry calculations showed optimal normal tissue and tumor absorbed doses, and the patient is clinically well after 3 months.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Czibor S, Bibok A, Horváthy D, et al. Radioembolization Planning With Dual-Isotope Acquisition of 166 Ho-Labeled Microparticles and 99m Tc-Mebrofenin. Clin Nucl Med. 2023. PMID: 37290424. doi:10.1097/RLU.0000000000004732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。